Skip to content

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Kerry Denies Discussing Israeli Strikes in Syria With Iranian

Show Me

Buck Sexton: ‘Border Czar’ Kamala Harris ‘Hasn’t Been Able To Find Her Way Down There Yet’ And Won’t Want To | Video 3 Minutes 25 Seconds

Show Me

It’s Been Obvious To Most Americans For Some Time Now | “Tucker: The Democratic Party Is Now A Religious Cult” | Video: 5 Minutes 39 Seconds

Show Me

John Kerry Wrong On The Middle East, Wrong On Climate Change | Video: 5 Minutes 48 Seconds

Show Me

When Democrats & Their Mainstream Media Allies Screams Cult, They Should Look In The Mirror | “Marianne Williamson Reveals the Democrats Are a Cult”

Show Me

It Appears John Kennedy Discovered Early On Why The Biden Administration Chose John Kerry | Here’s Biden’s New Energy Policy, “We’re not going to produce our own oil. Instead, we’re gonna buy oil from countries that hate us so they’ll have more money to buy weapons to kill us.” | Video 3 Minutes 7 Seconds

Show Me

Rose McGowan: Democrats ‘Are in a Deep Cult’

Show Me

We Should Have Already Been Toast | John Kerry Makes DIRE Prediction About Global Warming – in 2014! | Video: 23 Seconds

Show Me

Days Before John Kerry’s Malfeasance Confirmed | “Navarro: John Kerry is a ‘Useful Idiot on Steroids'” | Video: 4 Minutes 18 Seconds

Show Me

Psaki’s Unhelpful Response To John Kerry Leaking Israel’s Covert Military Action To Iran | Video: 39 Seconds

Show Me

D.C. Police Department Data Is Leaked in a Cyberattack

Show Me

April 26, 2021 | Nightly News Rebroadcast | Video: 53 Minutes 30 Seconds

Show Me

The Enemy Within | “John Kerry Divulged HUNDREDS of Israel’s Covert Attacks to Iran, Leak Reveals”

Show Me

Rand Paul Demonstrates How To Respond To Hostile Mainstream Media On Election Fraud | Here You Will Find The Full Exchange | Video: 6 Minutes 32 Seconds

Show Me

Maricopa County Judge Recuses Himself from 2020 Election Audit Case

Show Me

Bannon’s War Room |Saturday Edition Hour 1 | Recorded April 26, 2021 | Video: 48 Minutes 21 Seconds

Show Me

Bannon’s War Room |Saturday Edition Hour 2 | Recorded April 26, 2021 | Video: 48 Minutes 21 Seconds

Show Me

Bannon’s War Room |Evening Edition | Recorded April 26, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Analysis: Three Vulnerable Senate Democrats Give GOP Shot Retaking Upper Chamber

Show Me

Texas state lawmaker says that according to science there are 6 biological sexes

Show Me

China: Further information: Uyghur held in solitary confinement for 2 years: Ekpar Asat

Show Me

Oscars 2021: Ricky Gervais trolls ‘host-less’ Academy Awards and tweets 2020 Golden Globes monologue

Show Me

Minnesota AG explains why Floyd’s death not charged as hate crime

Show Me

Spanish Man Charged With Infecting 22 People With COVID-19

Show Me

Los Angeles Hypocrites Remove Homeless Camp and Erect Fence to Protect the Stars at Oscars

Show Me

You’re no safer from COVID-19 social distancing at 6 or 60 feet, study says

Show Me

Iran’s Foreign Minister, in Leaked Tape, Says Revolutionary Guards Set Policies

Show Me

‘TRUTH’ With RFK, Jr. and Dr. Joseph Mercola: The Shadowy Alliance Between Big Pharma and Big Tech

Show Me

SpaceX craft had close call with UFO after launching into orbit

Show Me

After Finding a Christmas Wish List Tied to a Balloon, This Man Drove Hundreds of Miles to Make Two Little Girls’ Dreams Come True

Show Me

FBI Releases Seth Rich Documents | First Names On Page One? Email From Peter Strzok to Lisa Page

Show Me

Cuomo’s Office Won’t Reveal What It Told DOJ About CCP Virus Deaths at Nursing Homes

Show Me

Maxine Waters’s Long History of Reckless Rhetoric

Show Me

Obama administration scientist says climate ‘emergency’ is based on fallacy

Show Me

Colorado’s Victim Rights Act leaves some crime victims without protection

Show Me

Donald Trump Supporters Square Off Against GOP Leadership in Savannah

Show Me

Trump to Hannity: “Big Tech should face antitrust scrutiny”

Show Me

Hospitals Overrun as India’s COVID-19 Infections Surge

Show Me

Health officials are dropping outdoor mask mandates, following numerous studies

Show Me

POLL: Most say government going too far prosecuting Trump supporters after Jan rally

Show Me